Interacting Drugs |
Rosiglitazone and metformin vs Deferasirox |
Security Level |
 |
Mechanism |
Deferasirox: May increase the serum concentration of CYP2C8 Substrates (High risk). |
Management |
Monitor therapy |
Rosiglitazone and metformin vs Deferasirox
Post Review about Rosiglitazone and metformin vs Deferasirox Click here to cancel reply.
Other Interactions of Rosiglitazone and metformin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.